Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe PH
NCT06605326Phase 4Completed
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Jan 2015
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of treprostinil in pulmonary arterial hypertension (PAH), Pulmonary Hypertension Due To Chronic Lung Disease (PH-CLD), sponsored by Guangzhou Institute of Respiratory Health. Started Jan 2015; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)Pulmonary Hypertension Due To Chronic Lung Disease (PH-CLD)
Beyond the preview
Go deeper on NCT06605326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605326.